- Home
- BBIO vs CR Comparison
BBIO vs CR Comparison
Compare BBIO & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- CR
- Stock Information
- Founded
- BBIO 2015
- CR 1855
- Country
- BBIO United States
- CR United States
- Employees
- BBIO N/A
- CR N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- CR Metal Fabrications
- Sector
- BBIO Health Care
- CR Industrials
- Exchange
- BBIO Nasdaq
- CR Nasdaq
- Market Cap
- BBIO 9.4B
- CR 11.1B
- IPO Year
- BBIO 2019
- CR N/A
- Fundamental
- Price
- BBIO $53.33
- CR $184.12
- Analyst Decision
- BBIO Strong Buy
- CR Strong Buy
- Analyst Count
- BBIO 16
- CR 5
- Target Price
- BBIO $64.44
- CR $222.20
- AVG Volume (30 Days)
- BBIO 2.1M
- CR 326.1K
- Earning Date
- BBIO 11-11-2025
- CR 10-27-2025
- Dividend Yield
- BBIO N/A
- CR 0.50%
- EPS Growth
- BBIO N/A
- CR 44.57
- EPS
- BBIO N/A
- CR 6.02
- Revenue
- BBIO $235,812,000.00
- CR $2,227,200,000.00
- Revenue This Year
- BBIO $115.97
- CR $10.69
- Revenue Next Year
- BBIO $65.50
- CR $10.98
- P/E Ratio
- BBIO N/A
- CR $30.50
- Revenue Growth
- BBIO 7.62
- CR 18.63
- 52 Week Low
- BBIO $21.72
- CR $127.04
- 52 Week High
- BBIO $54.60
- CR $203.89
- Technical
- Relative Strength Index (RSI)
- BBIO 60.01
- CR 45.63
- Support Level
- BBIO $49.94
- CR $179.32
- Resistance Level
- BBIO $54.29
- CR $186.79
- Average True Range (ATR)
- BBIO 2.06
- CR 4.39
- MACD
- BBIO -0.18
- CR -0.24
- Stochastic Oscillator
- BBIO 73.81
- CR 35.50
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.